Literature DB >> 30372549

The DosR antigen Rv1737c from Mycobacterium tuberculosis confers inflammation regulation in tuberculosis infection.

Xiaoling Gao1, Cong Wu2, Xiaoxia Wang2, Hui Xu1, Yu Wu1, Yonghong Li1, Yanjuan Jia1, Chaojun Wei1, Wenhua He2, Yongxiang Wang2, Benzhong Zhang2.   

Abstract

There is an urgent need to identify the potential risk factors for activating latent Mycobacterium tuberculosis infection. In this study, we evaluated the immune function of Rv1737c, which is a latency-associated antigen of dormancy survival regulator (DosR) of M. tuberculosis in a mouse model. Our data showed that mice pretreated with recombinant Rv1737c (rRv1737c) exhibited higher levels of antigen-specific antibodies (IgG, IgM and IgA) than sham-treated mice. Following Bacilli Calmette-Guerin (BCG) challenge, rRv1737c adjuvanted with cholera toxin subunit B (CTB) induced diffuse lung inflammation and fibrosis compared to the control mice. The inflammatory pathogenesis due to rRv1737c pre-exposure was associated with a switch in the macrophage phenotype from M1 to activated M2 and was characterized by IL-10 production. Intracellular cytokine analysis further showed that the rRv1737c-pretreated mice exhibited an increased frequency of Th2 cells in the lungs, lymph nodes and spleen after BCG challenge. Furthermore, IFN-γ expression increased in the lungs after rRv1737c pretreatment compared to that in the sham mice. Accordingly, lung cells from rRv1737c-immunized mice stimulated with killed BCG produced higher levels of multiple cytokines, such as IFN-γ, IL-10 and IL-6. The results confirmed that the pathological features of rRv1737c promoted inflammation. Overall, our findings provide direct evidence of the pro-inflammatory function of rRv1737c in a murine model of BCG infection, indicating that Rv1737c is a pathogenic antigen of M. tuberculosis and may be key to the recurrence of latent infection.
© 2018 The Foundation for the Scandinavian Journal of Immunology.

Entities:  

Keywords:  DosR antigens; M2 macrophages; Mycobacterium tuberculosis; Rv1737c

Mesh:

Substances:

Year:  2018        PMID: 30372549     DOI: 10.1111/sji.12729

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  2 in total

1.  Clinical Significance of M1/M2 Macrophages and Related Cytokines in Patients with Spinal Tuberculosis.

Authors:  Liang Wang; Xiaoqian Shang; Xinwei Qi; Derong Ba; Jie Lv; Xuan Zhou; Hao Wang; Nazierhan Shaxika; Jing Wang; Xiumin Ma
Journal:  Dis Markers       Date:  2020-05-20       Impact factor: 3.434

2.  Expression and Clinical Significance of lncRNA NEAT1 in Patients with Spinal Tuberculosis.

Authors:  Jianping Zheng; Xiangxin Wang; Jiandang Shi; Jun Tian; Xiuqin Chang; Xiaoping Wang; Qiang Ye
Journal:  Dis Markers       Date:  2022-04-14       Impact factor: 3.464

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.